ORAI1 and Immunodeficiency: We next tested P11 efficacy on two lymphoblastoid cell lines (“LCL”) established from an Orai1-deficient with a severe combined immunodeficiency (“LCL Orai1−”) and a healthy (“LCL Orai1+”) patients (Figure 3C [19]).